Cheviot Value Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cheviot Value Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	7,200 +100	+1%	+$13.5K	0.12%	61
2026 Q1	$907K	Hold	7,100	–	–	0.09%	63
2025 Q4	$894K	Buy	7,100 +75	+1%	+$8.6K	0.09%	63
2025 Q3	$787K	Buy	7,025 +50	+0.7%	+$4.5K	0.08%	70
2025 Q2	$596K	Buy	6,975 +90	+1%	+$7.18K	0.07%	70
2025 Q1	$569K	Buy	+6,885	New	+$615K	0.07%	70

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Cheviot Value Management's XBI Position: Q2 2026 in Review

Cheviot Value Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.4% in Q2 2026, buying an estimated $13.5K and bringing the position to 7,200 shares worth $1.14M. The position accounts for 0.12% of the portfolio, ranked #61.

Cheviot Value Management first reported a position in XBI in Q1 2025 and has held it in 6 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Cheviot Value Management held 7,200 shares of State Street SPDR S&P Biotech ETF worth $1.14M as of Q2 2026.
Cheviot Value Management bought 100 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $13.5K.
State Street SPDR S&P Biotech ETF made up 0.12% of Cheviot Value Management's portfolio in Q2 2026, its #61 holding.
Cheviot Value Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 6 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.